Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Express Scripts
Queensland Health
Baxter
McKinsey
Healthtrust
Julphar
Deloitte

Generated: December 11, 2018

DrugPatentWatch Database Preview

KANAMYCIN SULFATE Drug Profile

« Back to Dashboard

Which patents cover Kanamycin Sulfate, and when can generic versions of Kanamycin Sulfate launch?

Kanamycin Sulfate is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Loch, Pharmafair, Solopak, Warner Chilcott, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in KANAMYCIN SULFATE is kanamycin sulfate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the kanamycin sulfate profile page.

Summary for KANAMYCIN SULFATE
Drug patent expirations by year for KANAMYCIN SULFATE
Medical Subject Heading (MeSH) Categories for KANAMYCIN SULFATE
Synonyms for KANAMYCIN SULFATE
(1S,2R,3R,4S,6R)-4,6-diamino-3-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
(1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)te
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol; sulfuric acid
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acid
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4,5-triol
11025-65-3
11030-21-0
11033-61-7
133-92-6
133K926
19079-03-9
25389-94-0
3847-27-6
4,6-Diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-alpha-D-glucoside
4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside
59-01-8
64013-69-0
70560-51-9
8063-07-8
936337-76-7
AB00513827
AC1L1LNI
AC1L9B21
AK163185
AKOS025293505
AKOS025310124
Ambap133-92-6
Amforol (Veterinary)
API0003071
API0003073
API0003074
AS-14003
BC678130
BDBM50031282
BIK0126
BPBio1_000669
BRD-K08327065-065-01-9
BRN 0061647
BSPBio_000607
C01822
C08046
C18H36N4O11
C18H36N4O11.H2SO4
CA001526
CA002717
CA006471
CA010648
Cantrex
CAS-25389-94-0
CCG-220394
CHEBI:17630
CHEBI:6109
CHEMBL1384
CHEMBL1446
Cristalomicina
CS-1140
CTK8G0428
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1,4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1->4))-2-deoxy-, sulfate (1:1) (salt)
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1-4))-2-deoxy-, sulfate (1:1) (salt)
D00866
D03262
DB01172
DivK1c_000024
DSSTox_CID_27524
DSSTox_GSID_47524
DSSTox_RID_82394
DTXSID1047524
DTXSID3023184
EINECS 200-411-7
EINECS 223-347-1
EINECS 246-933-9
EQK9Q303C5
Glucopyranoside, 4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-, D-
HMS2096O09
HMS500B06
HSDB 3107
HY-16566A
IDI1_000024
J10342
J80EX28SMQ
K0047
K434
KAN
Kanabristol
Kanacedin
kanacin
Kanamicina
Kanamicina [Italian]
kanamycin
Kanamycin (sulfate)
Kanamycin [INN:BAN]
KANAMYCIN A
Kanamycin A sulfate
Kanamycin A sulphate
Kanamycin acid sulfate
Kanamycin Base
Kanamycin monosulfate
Kanamycin monosulfate (JP17)
Kanamycin monosulfate [JAN]
Kanamycin monosulfate, Cell Culture Grade
Kanamycin solution from Streptomyces kanamyceticus, 10 mg/mL in 0.9% NaCl, sterile-filtered, BioReagent, suitable for cell culture
Kanamycin solution from Streptomyces kanamyceticus, 50 mg/mL in 0.9% NaCl, BioReagent, liquid, sterile-filtered, suitable for cell culture
Kanamycin sulfate (JP17)
Kanamycin sulfate (TN)
Kanamycin sulfate (USP)
Kanamycin sulfate [USP:JAN]
Kanamycin sulfate from Streptomyces kanamyceticus, Animal Component-free
Kanamycin sulfate from Streptomyces kanamyceticus, meets USP testing specifications, powder
Kanamycin sulfate from Streptomyces kanamyceticus, powder, BioReagent, suitable for cell culture, suitable for plant cell culture
Kanamycin sulfate Streptomyces kanamyceticus, powder, gamma-irradiated
Kanamycin sulfate, Antibiotic for Culture Media Use Only
Kanamycin sulfate, mixture of Kanamycin A (main component) and Kanamycin B and C
Kanamycin Sulfate, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Kanamycin sulphate
KANAMYCIN, SULFATE (1:1) (salt)
kanamycin; sulfuric acid
Kanamycine
Kanamycine [INN-French]
Kanamycinum
Kanamycinum [INN-Latin]
Kanamytrex
Kanaqua
Kanasig
Kanatrol
Kanescin
Kanicin
Kannasyn
Kano
Kantrex (1:1 sulfate)
Kantrex (TN)
Kantrim
KBio1_000024
Kenamycin A
Klebcil
Klebcil (1:1 sulfate)
KM (the Antibiotic)
KM0269
KSC-27-052C
KUC109575AC
Liposomal Kanamycin
LS-146900
MFCD00070253
MolPort-006-069-166
MolPort-006-167-728
NCGC00016792-01
NCGC00179506-01
NCGC00260363-01
NINDS_000024
O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine
O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine Monosulfate
OOYGSFOGFJDDHP-KMCOLRRFSA-N
Ophtalmokalixan
Otokalixin
Prestwick3_000394
s2315
SBUJHOSQTJFQJX-NOAMYHISSA-N
SCHEMBL2735
SCHEMBL65538
SMP2_000007
ST24047464
Tox21_110612
Tox21_202817
trahydro-2H-pyran-3,4,5-triol sulfate
UNII-EQK9Q303C5
UNII-J80EX28SMQ
UNII-OW1N4G4R9W component OOYGSFOGFJDDHP-KMCOLRRFSA-N
UNII-RUC37XUP2P component SBUJHOSQTJFQJX-NOAMYHISSA-N
W-5066
ZINC8214590
ZX-AFC000777

US Patents and Regulatory Information for KANAMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062504-003 Apr 5, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062520-003 May 9, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Intl Medication KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062466-001 Sep 30, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 065111-002 Dec 17, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmafair KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062668-001 May 7, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Loch KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 063025-001 Jul 31, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Medtronic
McKinsey
Cantor Fitzgerald
Fuji
Harvard Business School
Cipla
Deloitte
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.